FDA Approves EndoSerter Device for Corneal Transplants

Ocular Systems has received FDA clearance to market its product EndoSerter, a device for inserting replacement cells into the eye during a type of corneal transplant, according to a company release.

Advertisement

EndoSerter is used for a type of corneal transplant called endothelial keratoplasty, which occurs when a patient needs a thin layer of endothelial cells replaced but does not require a full corneal transplant. The device inserts cells into the eye, protecting the corneal tissue from damage.

The device is intended to replace forceps, which can crush tissue while gripping the cornea, according to the release. EndoSerter is designed to result in a smaller incision, no sutures and reduced operating time.

Read more on ophthalmology:

New Indiana Ophthalmology Surgery Center Planned for Fort Wayne

10 Statistics on Ophthalmology Revenue in Surgery Centers

Payment Policy for an A-C IOL Inserted Following Removal of a Cataract in Surgery Centers

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

  • Across the country, states are rewriting the rules for certified registered nurse anesthetists, shifting away from physician supervision requirements and…

  • As the ASC industry continues to grow alongside new waves of surgical innovation, patient preferences and shifts to value-based care,…

  • A Pleasant View, Utah-based physician has been indicted on charges of obtaining unapproved drugs from China and selling them to…

Advertisement

Comments are closed.